| [1] |
LIU Xun, ZHOU Tingting, ZHU Zibing, TAN Jin, LI Qun.
Arecoline promotes oral submucous fibrosis by upregulating PI3K/Akt/mTOR signaling pathway in vivo and in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 865-875.
|
| [2] |
GAO Zitian, CHEN Yu, HE Haidong, TANG Yuyan.
Short-chain fatty acids modulate the role of NLRP3 inflammatory vesicle pathway in CKD and the progress of traditional Chinese medicine intervention
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 812-819.
|
| [3] |
DING Ding, WU Shengnan, WANG Ancai, WANG Deguo.
Research progress on the inhibition of cardiac remodeling by vericiguat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 858-863.
|
| [4] |
WANG Guowei, ZHUO Tao, ZHENG Quanwei, LI Mengying, LI Jiehui, LIU Jianhang.
Cuttlebone extract on wound healing and VEGF/PI3K/Akt pathway in rats with refractory ulcers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 577-585.
|
| [5] |
LIU Yeyuan, QI Yafeng, ZHANG Maofu, LI Xinyu, SHEN Yanyun, LIU Yu, ZHANG Shangzu, LI Yangyang, ZHANG Liying, ZHANG Zhiming.
Research progress of traditional Chinese medicine intervention in chemotherapy renal injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 556-569.
|
| [6] |
WANG Peipei, PAN Linkun, YANG Kui, FENG Dandan.
Qingluo Yin inhibits synovial angiogenesis induced by adjuvant in arthritis rats by regulating HIF-1α/VEGF pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 366-373.
|
| [7] |
LIU Xuan, FENG Cuijuan, WANG Yiqiang, LI Fang.
Research progress of miRNA in ulcerative colitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 917-929.
|
| [8] |
LI Quanyang, HAO Yafang, WU Guotai, WANG Ruiqiong.
Research progress on the regulation of endometriosis by PI3K/Akt signaling pathway and the intervention effect of traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 501-511.
|
| [9] |
YU Dan, LIU Zongtao, YAN Xiaohong, CHENG Jing, LI lin.
Effects of osthole on renal oxidative stress injury in aged spontaneously hypertensive rats by regulating PI3K/Akt/mTOR signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 277-282.
|
| [10] |
ZHANG Zhipeng, CHEN Ziqi, TIAN Jianhui.
The attenuating and potentiating effects of traditional Chinese medicine in immune checkpoint therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 339-347.
|
| [11] |
WANG Xin, WANG Yifan, SHANG Muhong, LIU Yuyan, CHEN Guangliang.
Di'ao Xinxuekang activates IRS-1/PI3K/Akt signal pathway to improve insulin resistance in nonalcoholic fatty hepatitis mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 121-129.
|
| [12] |
ZHAO Quanming, YANG Mandou, HU Yibo, SU Youtong, PU Li, ZHANG Yu, LI Wenliang.
Research progress on drug treatment and drug resistance mechanism of gastrointestinal stromal tumors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 82-89.
|
| [13] |
YU Miaoying, WANG Yanhui, YAN Shi.
Research progress on molecular mechanism of traditional chinese medicine active ingredients interfering bone marrow mesenchymal stem cells senescence
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 99-106.
|
| [14] |
XU Jinhui, YUE Hongmei, LI Yating, LIU Miaomiao, WU Xingdong, ZHU Haobin.
Advances in the study of mesenchymal stem cells in obstructive sleep apnea hypoventilation syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 114-120.
|
| [15] |
LUO Shiping, ZHANG Jie, YU Yushuai, SONG Chuangui.
Advances in targeted therapy for HER2-positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 876-886.
|